VEGENICS PTY LIMITED
Patent Owner
Stats
- 13 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Feb 20, 2018 most recent publication
Details
- 13 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 326 Total Citation Count
- Aug 21, 1997 Earliest Filing
- 27 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9896499 Growth factor antagonists for organ transplant alloimmunity and arteriosclerosisApr 15, 15Feb 20, 18[A61K, C12N, C07K]
9260526 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapyNov 17, 14Feb 16, 16[C07H, A61K, C12N, C07K]
9073997 Growth factor antagonists for organ transplant alloimmunity and arteriosclerosisFeb 01, 08Jul 07, 15[A61K, C07K]
8940695 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapyJan 06, 06Jan 27, 15[A61K, C12N, C07K]
8025886 Modified VEGF-A with improved angiogenic propertiesAug 15, 06Sep 27, 11[A61K, C07H, C12P, A61F, C12N, A61B, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0072,511 FLT4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPYAbandonedApr 18, 13Mar 13, 14[A61K]
8637262 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereofExpiredOct 05, 12Jan 28, 14[G01N, C07K]
8461109 Method of enhancing the acceptance and/or healing of a skin graftExpiredApr 17, 12Jun 11, 13[A61K, C07K]
8383788 C-Fos induced growth factor (FIGF) and DNA encoding sameExpiredMay 07, 02Feb 26, 13[C07H, A61K, C12N, C07K]
2013/0039,930 BIOMARKER FOR SENSITIVITY TO THERAPY WITH A NOTCH INHIBITORAbandonedJun 08, 12Feb 14, 13[A61K, C12Q, G01N, G06F, A61P]
8357669 Method of treatment for lymphedema comprising administering a polynucleotide encoding VEGF-DExpiredSep 23, 11Jan 22, 13[A61K]
8282931 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereofExpiredSep 10, 10Oct 09, 12[A61K, C07K]
8278098 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteinsExpiredJan 28, 11Oct 02, 12[C12N]
2012/0207,671 COMBINATION TREATMENT WITH VEGF-C ANTAGONISTSAbandonedApr 05, 11Aug 16, 12[A61K, A61P]
8227410 Methods of stimulating wound healing by administration of vascular endothelial growth factor D (VEGF-D)ExpiredMar 16, 11Jul 24, 12[A61K, C07K]
2012/0141,424 Materials and Methods for the Treatment of HypertensionAbandonedJan 07, 10Jun 07, 12[A61K, A61P]
2012/0071,406 MODIFIED VEGF-A WITH IMPROVED ANGIOGENIC PROPERTIESAbandonedAug 19, 11Mar 22, 12[A61K, C07H, C12N, A61P, C07K]
2011/0305,703 ISOLATED VEGF-C AND VEGF-D PEPTIDES AND USES THEREOFAbandonedDec 08, 09Dec 15, 11[A61K, C12N, G01N, A61P, C40B, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.